Cargando…

ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients

Colorectal cancer (CRC) is a heterogeneous disease with a high mortality rate and is still lacking an effective treatment. Our goal is to develop a robust prognosis model for predicting the prognosis in CRC patients. In this study, 871 stage II and III CRC samples were collected from six gene expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Mingguang, He, Jianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793313/
https://www.ncbi.nlm.nih.gov/pubmed/26989635
http://dx.doi.org/10.7717/peerj.1804